Small-Molecule Dual PLK1 and BRD4 Inhibitors are Active Against Preclinical Models of Pediatric Solid Tumors

  • Natalie Timme
  • , Youjia Han
  • , Shuai Liu
  • , Hailemichael O. Yosief
  • , Heathcliff Dorado García
  • , Yi Bei
  • , Filippos Klironomos
  • , Ian C. MacArthur
  • , Annabell Szymansky
  • , Jennifer von Stebut
  • , Victor Bardinet
  • , Constantin Dohna
  • , Annette Künkele
  • , Jana Rolff
  • , Patrick Hundsdörfer
  • , Andrej Lissat
  • , Georg Seifert
  • , Angelika Eggert
  • , Johannes H. Schulte
  • , Wei Zhang
  • Anton G. Henssen

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)221-232
Number of pages12
JournalTranslational Oncology
Volume13
Issue number2
DOIs
StatePublished - Feb 2020

ASJC Scopus Subject Areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Small-Molecule Dual PLK1 and BRD4 Inhibitors are Active Against Preclinical Models of Pediatric Solid Tumors'. Together they form a unique fingerprint.

Cite this